Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Thromboembolism × Fluorodeoxyglucose F18 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 16 Breast Neoplasms 12 Lung Neoplasms 9 Carcinoma, Renal Cell 7 Rectal Neoplasms 5 Pancreatic Neoplasms 5 Neoplasms 5 Lymphoma 5 Colorectal Neoplasms 5 Colonic Neoplasms 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Glioblastoma 4 Esophageal Neoplasms 4 Breast Neoplasms, Male 4 Sarcoma 3 Melanoma 3 Lymphoma, Large B-Cell, Diffuse 3 Kidney Neoplasms 3 Head and Neck Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Brain Neoplasms 3 Adenocarcinoma Of Esophagus 3 Urinary Bladder Neoplasms 2 Unspecified Adult Solid Tumor, Protocol Specific 2 Thyroid Neoplasms 2 Thyroid Cancer, Papillary 2 Stomach Neoplasms 2 Spinal Cord Neoplasms 2 Salivary Gland Neoplasms 2

Interventions

Enoxaparin 4 Saline Solution 3 Warfarin 2 Tinzaparin 2 Dalteparin 2 Aspirin 2 enoxaparin sodium 1 edoxaban 1 alvocidib 1 Watchful Waiting 1 Tranexamic Acid 1 Sodium Chloride 1 Sodium Bicarbonate 1 Nadroparin 1 Lenalidomide 1 Ketoconazole 1 Immunoenzyme Techniques 1 High-Energy Shock Waves 1 Heparin, Low-Molecular-Weight 1 Heparin 1 Gemcitabine 1 Fondaparinux 1 Fluorodeoxyglucose F18 1 Fluoridation 1 Estramustine 1 Enzyme-Linked Immunosorbent Assay 1 Doxorubicin 1 Docetaxel 1 Clopidogrel 1 Bleeding Time 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00964275 2014-12-08

MVTEP

University Hospital, Brest

Phase NA Completed

Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡